{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:05:27Z","timestamp":1779797127603,"version":"3.53.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.therap.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:21:55Z","timestamp":1778023315000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7954-5266","authenticated-orcid":false,"given":"Emmanuel","family":"Gachiniard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Berthault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Piroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00eblle","family":"Veyrac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2026.04.005_bib0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.therap.2023.09.011","article-title":"Cutaneous adverse drug reactions","volume":"79","author":"Bettuzzi","year":"2024","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2026.04.005_bib0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.therap.2026.04.005_bib0055","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/archinte.162.19.2240","article-title":"Ticlopidine-induced lupus: a report of 4 cases","volume":"162","author":"Spiera","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.therap.2026.04.005_bib0060","doi-asserted-by":"crossref","first-page":"102705","DOI":"10.1016\/j.autrev.2020.102705","article-title":"Characterization of drug-induced cutaneous lupus: analysis of 1994 cases using the WHO pharmacovigilance database","volume":"20","author":"Kawka","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.therap.2026.04.005_bib0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.annder.2021.02.006","article-title":"Cutaneous drug-induced lupus erythematosus: clinical and immunological characteristics and update on new associated drugs","volume":"148","author":"Bataille","year":"2021","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.therap.2026.04.005_bib0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.therap.2022.03.001","article-title":"Pharmacovigilance and drug safety: fair prescribing and clinical research","volume":"77","author":"Montastruc","year":"2022","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2026.04.005_bib0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2515\/therapie\/2009041","article-title":"Guidelines for submitting adverse event reports for publication","volume":"64","author":"Kelly","year":"2009","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2026.04.005_bib0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2515\/therapie\/2013016","article-title":"Updating the French method for the causality assessment of adverse drug reactions","volume":"68","author":"Arimone","year":"2013","journal-title":"Therapie"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595726000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595726000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:16:15Z","timestamp":1779794175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595726000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":8,"alternative-id":["S0040595726000624"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2026.04.005","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}